| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |